4//SEC Filing
Greenstein Leonard M. 4
Accession 0001519692-23-000010
CIK 0001819790other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 8:04 PM ET
Size
7.8 KB
Accession
0001519692-23-000010
Insider Transaction Report
Form 4
Greenstein Leonard M.
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-21$12.89/sh−326$4,202→ 32,463 total - Sale
Common Stock
2023-03-22$12.64/sh−332$4,196→ 32,131 total - Sale
Common Stock
2023-03-23$12.15/sh−346$4,204→ 31,785 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001519692
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 8:04 PM ET
- Size
- 7.8 KB